The programme features headline data from pivotal Phase III trials, including PREVAIL in gMG, KOMET in NF1-PN, and CHAMPION-NMOSD, alongside real-world evidence supporting established therapies
The launch saw the presence of senior clinicians and leadership from the Manipal Hospitals network
_256_384.jpg)
Effective recovery at home begins with well-defined care plans that outline treatment protocols, recovery milestones, and monitoring requirements tailored to individual patient needs
The event showcased latest breakthroughs in minimally invasive surgery, organ-preservation strategies, and targeted therapies
The initiative is aimed at strengthening the district-level screening and chronic disease management infrastructure
The deal gives Vertex access to Halozyme’s Hypercon technology for up to three drug targets
The data will be presented at the 2026 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Congress in Munich, April 17-21
TriNetX will provide Regeneron secure, licensed access to de-identified health data from its global network of health system partners
Under the collaboration, Symeres will test Ambagon’s newly designed molecular glues using in vitro assays and mechanistic studies
Multi-year CDMO partnership combines AI-led virtual development, precision chemistry and GMP manufacturing to accelerate five high-science APIs across regulated markets
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
